Thromb Haemost 1996; 75(05): 772-777
DOI: 10.1055/s-0038-1650365
Original Article
Schattauer GmbH Stuttgart

Detection of Circulating Tissue Factor and Factor VII in a Normal Population

Sybille Albrecht
The Institut für Pathologie, Technische Universitat Dresden, Germany
,
Matthias Kotzsch
The Institut für Pathologie, Technische Universitat Dresden, Germany
,
Gabriele Siegert
1   Institut für Klinische Chemie und Laboratoriumsmedizin, Technische Universitat Dresden, Germany
,
Thomas Luther
The Institut für Pathologie, Technische Universitat Dresden, Germany
,
Heinz Großmann
The Institut für Pathologie, Technische Universitat Dresden, Germany
,
Marianne Großer
The Institut für Pathologie, Technische Universitat Dresden, Germany
,
Martin Müller
The Institut für Pathologie, Technische Universitat Dresden, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 20. Juli 1995

Accepted after resubmission 05. Februar 1996

Publikationsdatum:
10. Juli 2018 (online)

Summary

The plasma tissue factor (TF) concentration was correlated to factor VII concentration (FVIIag) and factor VII activity (FVIIc) in 498 healthy volunteers ranging in age from 17 to 64 years. Immunoassays using monoclonal antibodies (mAbs) were developed for the determination of TF and FVIIag in plasma. The mAbs and the test systems were characterized. The mean value of the TF concentration was 172 ± 135 pg/ml. TF showed no age- and gender-related differences. For the total population, FVIIc, determined by a clotting test, was 110 ± 15% and the factor VIlag was 0.77 ± 0.19 μg/ml. FVII activity was significantly increased with age, whereas the concentration demonstrated no correlation to age in this population. FVII concentration is highly correlated with the activity as measured by clotting assay using rabbit thromboplastin. The ratio between FVIIc and FVIIag was not age-dependent, but demonstrated a significant difference between men and women. Between TF and FVII we could not detect a correlation.

 
  • References

  • 1 Edgington TS, Mackman N, Brand K, Ruf F. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67-79
  • 2 Rapaport SI, Rao LVM. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 12: 1111-1121
  • 3 Carson SD, Brozna JP. The role of tissue factor in the production of thrombin. Blood Coagul Fibrinol 1993; 4: 281-292
  • 4 Drake DA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol 1989; 134: 1087-1097
  • 5 Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal antihuman tissue factor antibody. Thromb Res 1990; 59: 421-437
  • 6 Callander NS, Varki N, Rao LVM. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992; 70: 1194-1201
  • 7 Sturm U, Luther T, Albrecht S, Flossel C, Grossmann H, Muller M. Immu-nohistological detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies. Virchows Archiv A Pathol Anat 1992; 42: 79-86
  • 8 Flossel C, Luther T, Muller M, Albrecht S, Kasper M. Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue. Histochemistry 1994; 101: 449-453
  • 9 Carvalho de SousaJ, Azevedo J, Soria C, Barros F, Ribeiro C, Parreira F, Caen J. FVII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation. Thromb Res 1988; 51: 165-173
  • 10 Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller GJ, North WRS, Stirling Y, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 02: 533-537
  • 11 Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 1-8
  • 12 Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci 1989; 86: 2839-2843
  • 13 Carson SD. Continuous chromogenic tissue factor assay: Comparison to clot-based assays and sensitivity established using pure tissue factor. Thromb Res 1987; 47: 379-387
  • 14 Giercksky KE, Bjprklid E, Prydz H, Renck H. Circulating tissue thromboplastin during hip surgery. Eur Surg Res 1979; 11: 296-300
  • 15 Kubota T, Andoh K, Sadakata H, Tanaka H, Kobayashi N. Tissue factor released from leukemic cells. Thromb Haemost 1991; 65: 59-63
  • 16 Bloem LJ, Chen L, Konigsberg WH, Bach R. Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearence of tissue factor antigen and procoagulant activity. J Cell Physiol 1989; 139: 418-423
  • 17 Albrecht S, Luther T, GroBmann H, Flossel C, Kotzsch M, Muller M. An ELISA for tissue factor using monoclonal antibodies. Blood Coagul Fibrinol 1992; 3: 263-270
  • 18 Albrecht S, Muller S, Siegert G, Luther T, Muller M. Plasma concentration of tissue factor and factor VII in patients after abdominal surgery. Thromb Res 1995; 77: 557-562
  • 19 Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S, Kuriyama R, Matsuzawa K, Hasegawa R, Aoki N. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 1994; 87: 343-347
  • 20 Takahashi H, Satoh N, Wada K, Takakuwa E, Seki Y, Shibata A. Tissue factor in plasma of patients with disseminated intravascular coagulation. AmerJ Hematol 1994; 46: 333-337
  • 21 Wada H, Nakase T, Nakaya R, Minamikawa K, Wakita Y, Kaneko T, Ohiwa M, Deguchi K, Shirakawa S. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Amer J Hematol 1994; 45: 232-236
  • 22 Fareed J, Callas DD, Hoppensteadt D, Bermes EW. Tissue factor antigen levels in various biological fluids. Blood Coagul Fibrinol 1995; 6: S32-S36
  • 23 Østerud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with menigococcal infection: related to an unfavorable prognosis. Thromb Haemost 1983; 49: 5-7
  • 24 Auger MJ, Mackie MJ. Monocyte procoagulant activity in breast cancer. Thromb Res 1987; 47: 77-84
  • 25 Bona R, Lee E, Rickies F. Tissue factor apoprotein: Intracellular transport and expresssion in shed membrane vesicles. Thromb Res 1987; 48: 487-500
  • 26 Dvorak HF, Van De Water L, Bitzer AM, Dvorak AM, Anderson D, Harvey A, Bach R, Davis GL, De Wolf W, Carvalho ACA. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cane Res 1983; 43: 4334-4342
  • 27 Francis JL, Carvalho M, Francis DA. The clinical value of tissue factor assays. Blood Coagul Fibrinol 1995; 6: S37-S44
  • 28 Scarabin P, Bonithon-Kopp C, Bara L, Malmejac A, Guize L, Samama M. Factor VII activation and menopausal status. Thromb Res 1990; 57: 227-234
  • 29 Kario K, Matsuo T, Nakao K. Factor VII hyperactivity in the elderly. Thromb Haemost 1991; 65: 25-27
  • 30 Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205
  • 31 Negri M, Arigliano PL, Talamini G, Carlini S, Manzato F, Bonadonna G. Levels of plasma factor VII and FVII activated forms as a function of plasma triglyceride levels. Atherosclerosis 1993; 99: 55-61
  • 32 Fair D. Quantitation of FVII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood 1983; 62: 784-791
  • 33 Broze G, Hickman S, Miletich J. Monoclonal anti-human factor VII antibodies: detection in plasma of a second protein antigenically and genetically related to factor VII. J Clin Invest 1985; 76: 937-946
  • 34 Boyer C, Wolf M, Rothchild C, Migaud M, Amiral J, Mannucci P, Meyer D, Larrieu MJ. An enzyme immunoassay (ELISA) for the quantitation of human factor VII. Thromb Haemost 1986; 56: 250-255
  • 35 Takase T, Tuddenham E, Chand S, Goodall AH. Technical methods: monoclonal antibodies to human factor VII: a one-step immunoradiometric assay for VII:Ag. J Clin Pathol 1988; 41: 337-341
  • 36 Coppola R, Tombesi S, Valentini F, Alborali S, Albertini A, Mannucci PM. Enzyme-linked immunosorbent assay of human factor VII based upon a monoclonal antibody that recognizes the native conformation of the protein. Thromb Res 1992; 68: 283-293
  • 37 Howard PR, Bovill EG, Pike J, Church WR, Tracy RP. FVII antigen levels in a healthy blood donor population. Thromb Haemost 1994; 72: 21-27
  • 38 Kitchen S, Malia RG, Preston FE. A comparison of methods for the measurement of activated factor FVII. Thromb Haemost 1992; 68: 301-305
  • 39 Broze GJ, Majerus PW. Human factor VII. Methods Enzymol 1981; 80: 228-237
  • 40 Morrissey JH. Tissue factor interactions with factor VII: measurement and clinical significance of factor Vila in plasma. Blood Coagul Fibrinol 1995; 6: S14-S19
  • 41 Hoffman CJ, Miller RH, Hultin MB. Correalation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1992; 12: 267-270
  • 42 Hayes TE, Pike J, Tracy RP. Factor VII assays. Arch Pathol Lab Med 1993; 117: 52-57